RGCON 2020 Focussed on Hemato-Oncology Update

▴ RGCON 2020
RGCON is focused on an all-important aspect of Hemato-oncology Update. Haematology-oncology includes such diseases as Leukaemia, Lymphoma, Myeloma, Iron Deficiency Anaemia, Haemophilia, etc.

RGCON 2020, the 19th Annual International Conference of Rajiv Gandhi Cancer Institute and Research Centre to be held in New Delhi from 7th - 9th February 2020 is focused on an all-important aspect of Hemato-oncology Update. Haematology-oncology includes such diseases as Leukaemia, Lymphoma, Myeloma, Iron Deficiency Anaemia, Haemophilia, Sickle Cell Disease, Thalassemia as well as cancers of other organs.

“Renowned national and international experts in the field of Haematology, Hemato-oncology & Stem Cell Transplant have committed their participation to share their views & deliver lectures on the current practices. As a distinctive feature, RGCON 2020 will cover latest updates from American Society of Haematology (ASH) and American Society of Clinical Oncology (ASCO) and various other events,” said Dr. Dinesh Bhurani, Director, Department of Hemato-Oncology & Bone Marrow Transplant, RGCIRC & Organising Secretary – RGCON 2020.

“Over the years, the aim of RGCON has been to bring eminent international and national faculty at one platform to share new advances in oncology and haematology leading to good interaction between faculty and delegates. We are fortunate to have distinguished international and national faculty for RGCON 2020 too,” said Dr. Sudhir Kumar Rawal, Medical Director and Chief of GenitoUro – Oncology Services RGCIRC.

Another unique feature of RGCON 2020 is a get together of Myeloma patients. The First Myeloma patient who got CarT cell treatment from China will also be present & share her experience.

Over the years, Hemato-Oncology has witnessed some path breaking advancements. Blood Cancers are treated with chemotherapy while some require bone marrow transplant. Now Targeted Therapy and Immunotherapy are fast taking the place of chemotherapy in treatment of blood cancers. Under immunotherapy, body’s own T cells are modified to kill cancer cells, added Dr. Bhurani.

Blood cancers account for around 20% of the total cancers in India. Different blood cancers occur at different age groups. Leukaemia occurs in Children while Lymphoma and Myeloma generally occur in old age.

Speaking about causes of blood cancers, Dr. Bhurani stated, blood cancers generally don’t have any direct causal relationship. Blood cancers are due to genetic changes in cells and generally not linked to any preventive causes.

The symptoms of blood cancers include fever and bleeding from any part – nose, mouth etc in case of leukaemia and lumps in neck in case of Lymphoma.

Tags : #Rgcon #Bloodcancer #Stemcell #Transplant #Hematooncology #Medicircle

About the Author

Team Medicircle

Related Stories

Loading Please wait...


Trending Now

Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024
10 compelling reasons why choosing right media platform Is important in healthcareApril 19, 2024
Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024
The Extension and Benefits of ABHA Linking with CGHS Beneficiary ID: What You Need to KnowApril 19, 2024
Mental Health Issues Impact Studies in 3 out 4 Female Students: PeakMind StudyApril 18, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 18, 2024
MiracleMe Introduces Revolutionary Orally Dissolving Plant-Based Nutrition ProductsApril 18, 2024
South Indian Bank signs MOU with Ashok Leyland Limited for Dealer FinancingApril 18, 2024
Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024